557 related articles for article (PubMed ID: 21932400)
1. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
Fowler KJ; Brown JJ; Narra VR
Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
3. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.
Marin D; Brancatelli G; Federle MP; Lagalla R; Catalano C; Passariello R; Midiri M; Vilgrain V
Clin Radiol; 2008 May; 63(5):577-85. PubMed ID: 18374723
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of liver lesions: exceptions and atypical lesions.
van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Preda A; Krestin GP
Curr Probl Diagn Radiol; 2008; 37(3):95-103. PubMed ID: 18436109
[TBL] [Abstract][Full Text] [Related]
6. The role of ADC measurement in differential diagnosis of focal hepatic lesions.
Onur MR; Çiçekçi M; Kayalı A; Poyraz AK; Kocakoç E
Eur J Radiol; 2012 Mar; 81(3):e171-6. PubMed ID: 21353418
[TBL] [Abstract][Full Text] [Related]
7. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents.
Goodwin MD; Dobson JE; Sirlin CB; Lim BG; Stella DL
Radiographics; 2011 Oct; 31(6):1547-68. PubMed ID: 21997981
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging in the characterization of focal liver lesions: efficacy of visual assessment.
Battal B; Kocaoglu M; Akgun V; Karademir I; Deveci S; Guvenc I; Bulakbasi N
J Comput Assist Tomogr; 2011; 35(3):326-31. PubMed ID: 21586924
[TBL] [Abstract][Full Text] [Related]
10. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
11. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Giovagnoni A; Paci E
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
[TBL] [Abstract][Full Text] [Related]
12. [Differentiation of focal liver lesions using contrast-enhanced MRT].
Heintz P; Ehrenheim C
Rofo; 1989 Mar; 150(3):297-306. PubMed ID: 2538880
[TBL] [Abstract][Full Text] [Related]
13. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
[TBL] [Abstract][Full Text] [Related]
14. ACG clinical guideline: the diagnosis and management of focal liver lesions.
Marrero JA; Ahn J; Rajender Reddy K;
Am J Gastroenterol; 2014 Sep; 109(9):1328-47; quiz 1348. PubMed ID: 25135008
[TBL] [Abstract][Full Text] [Related]
15. [Focal liver lesion, incidental finding].
Dietrich CF; Jenssen C
Dtsch Med Wochenschr; 2012 Oct; 137(41):2099-116. PubMed ID: 23033169
[TBL] [Abstract][Full Text] [Related]
16. [Dynamic MR tomography of intrahepatic tumors].
Hamm B; Felix R; Wolf KJ
Rofo; 1989 Apr; 150(4):434-41. PubMed ID: 2539622
[TBL] [Abstract][Full Text] [Related]
17. MultiHance: help or hype?
Bartolozzi C; Spinazzi A
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S151-9. PubMed ID: 10608411
[TBL] [Abstract][Full Text] [Related]
18. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Burke C; Alexander Grant L; Goh V; Griffin N
Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
[TBL] [Abstract][Full Text] [Related]
19. The ins and outs of liver imaging.
O'Neill EK; Cogley JR; Miller FH
Clin Liver Dis; 2015 Feb; 19(1):99-121. PubMed ID: 25454299
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
